Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Colorectal Neoplasms

Free Subscription Articles published in Cancer Retrieve available abstracts of 120 articles: HTML format

Single Articles

July 2021
1. BOEHMER U, Ozonoff A, Winter M, Berklein F, et al
   Health-related quality of life among colorectal cancer survivors of diverse sexual orientations.
   Cancer. 2021 Jul 8. doi: 10.1002/cncr.33762.
   PubMed     Abstract available
   
   
   May 2021
2. PRINTZ C
   Triple Chemotherapy Combination Improves Metastatic Colorectal Cancer Outcomes.
   Cancer. 2021;127:1547.
   PubMed    
   
   
   
3. PRINTZ C
   Study Links Surgical Skills to Fewer Long-Term Colon Cancer Complications: Findings showed that procedures performed by highly skilled surgeons resulted in a 70% reduction in 5-year mortality risk.
   Cancer. 2021;127:1545-1546.
   PubMed    
   
   
   
4. CHUDY-ONWUGAJE K, Huang WY, Su LJ, Purdue MP, et al
   Aspirin, ibuprofen, and reduced risk of advanced colorectal adenoma incidence and recurrence and colorectal cancer in the PLCO Cancer Screening Trial.
   Cancer. 2021 May 11. doi: 10.1002/cncr.33623.
   PubMed     Abstract available
   
   
   March 2021
5. WINKELS RM, Kampman E, Wu M
   Learning from East to West and vice versa: Clinical epidemiology of colorectal cancer in China.
   Cancer. 2021 Mar 31. doi: 10.1002/cncr.33444.
   PubMed    
   
   
   
6. SHI JF, Wang L, Ran JC, Wang H, et al
   Clinical characteristics, medical service utilization, and expenditure for colorectal cancer in China, 2005 to 2014: Overall design and results from a multicenter retrospective epidemiologic survey.
   Cancer. 2021 Mar 30. doi: 10.1002/cncr.33445.
   PubMed     Abstract available
   
   
   January 2021
7. NIU P, Lei F, Gu J
   Colorectal cancer and COVID-19: Do we need to raise awareness and vigilance?
   Cancer. 2021 Jan 26. doi: 10.1002/cncr.33217.
   PubMed    
   
   
   
8. WU Q, Zhang H, Zhong Y, Chua MLK, et al
   Reply to Colorectal cancer and COVID-19: Do we need to raise awareness and vigilance?
   Cancer. 2021 Jan 26. doi: 10.1002/cncr.33218.
   PubMed    
   
   
   December 2020
9. CECCHINI M, Kortmansky JS, Cui C, Wei W, et al
   A phase 1b expansion study of TAS-102 with oxaliplatin for refractory metastatic colorectal cancer.
   Cancer. 2020 Dec 22. doi: 10.1002/cncr.33379.
   PubMed     Abstract available
   
   
   
10. SHARMA KP, Leadbetter S, DeGroff A
    Characterizing clinics with differential changes in the screening rate in the Colorectal Cancer Control Program of the Centers for Disease Control and Prevention.
    Cancer. 2020 Dec 10. doi: 10.1002/cncr.33325.
    PubMed     Abstract available
    
    
    November 2020
11. LAM TYT, Wu PI, Tang RSY, Luk AKC, et al
    Mobile messenger-initiated reminders improve longitudinal adherence in a community-based, opportunistic colorectal cancer screening program: A single-blind, crossover randomized controlled study.
    Cancer. 2020 Nov 20. doi: 10.1002/cncr.33336.
    PubMed     Abstract available
    
    
    October 2020
12. ZAHND WE, Gomez SL, Steck SE, Brown MJ, et al
    Rural-urban and racial/ethnic trends and disparities in early-onset and average-onset colorectal cancer.
    Cancer. 2020 Oct 28. doi: 10.1002/cncr.33256.
    PubMed     Abstract available
    
    
    
13. SANCHEZ JI, Shankaran V, Unger JM, Madeleine MM, et al
    Inequitable access to surveillance colonoscopy among Medicare beneficiaries with surgically resected colorectal cancer.
    Cancer. 2020 Oct 23. doi: 10.1002/cncr.33262.
    PubMed     Abstract available
    
    
    
14. PRINTZ C
    One negative colonoscopy associated with a significant reduction in colorectal cancer risk.
    Cancer. 2020;126:4445.
    PubMed    
    
    
    August 2020
15. KIM SR, Tone A, Kim RH, Cesari M, et al
    Performance characteristics of screening strategies to identify Lynch syndrome in women with ovarian cancer.
    Cancer. 2020 Aug 18. doi: 10.1002/cncr.33144.
    PubMed     Abstract available
    
    
    July 2020
16. SHAIB WL, Zakka KM, Jiang R, Yan M, et al
    Survival outcome of adjuvant chemotherapy in deficient mismatch repair stage III colon cancer.
    Cancer. 2020 Jul 22. doi: 10.1002/cncr.33049.
    PubMed     Abstract available
    
    
    
17. WHEELER SB, O'Leary MC, Rhode J, Yang JY, et al
    Comparative cost-effectiveness of mailed fecal immunochemical testing (FIT)-based interventions for increasing colorectal cancer screening in the Medicaid population.
    Cancer. 2020 Jul 20. doi: 10.1002/cncr.32992.
    PubMed     Abstract available
    
    
    
18. GREEN BB, Meenan RT
    Colorectal cancer screening: The costs and benefits of getting to 80% in every community.
    Cancer. 2020 Jul 20. doi: 10.1002/cncr.32990.
    PubMed    
    
    
    June 2020
19. HALDAR R, Ricon-Becker I, Radin A, Gutman M, et al
    Perioperative COX2 and beta-adrenergic blockade improves biomarkers of tumor metastasis, immunity, and inflammation in colorectal cancer: A randomized controlled trial.
    Cancer. 2020 Jun 13. doi: 10.1002/cncr.32950.
    PubMed     Abstract available
    
    
    
20. 
    The Chicago Consensus on peritoneal surface malignancies: Management of colorectal metastases.
    Cancer. 2020;126:2534-2540.
    PubMed     Abstract available
    
    
    May 2020
21. HENLEY SJ, Thomas CC, Lewis DR, Ward EM, et al
    Annual report to the nation on the status of cancer, part II: Progress toward Healthy People 2020 objectives for 4 common cancers.
    Cancer. 2020;126:2250-2266.
    PubMed     Abstract available
    
    
    April 2020
22. GUPTA S, Bharti B, Ahnen DJ, Buchanan DD, et al
    Potential impact of family history-based screening guidelines on the detection of early-onset colorectal cancer.
    Cancer. 2020 Apr 20. doi: 10.1002/cncr.32851.
    PubMed     Abstract available
    
    
    
23. VIROSTKO J, Capasso A, Yankeelov TE, Goodgame B, et al
    Reply to Appropriate considerations of "rural" in National Cancer Data Base analyses.
    Cancer. 2020;126:1586-1587.
    PubMed    
    
    
    
24. ZAHND WE
    Appropriate considerations of "rural" in National Cancer Data Base analyses.
    Cancer. 2020;126:1585-1586.
    PubMed    
    
    
    
25. PRINTZ C
    Rates of anal cancer increase dramatically in the United States.
    Cancer. 2020;126:1375.
    PubMed    
    
    
    January 2020
26. GOLDSTONE SE
    Anal cancer prevention: Solving the puzzle piece by piece.
    Cancer. 2020 Jan 24. doi: 10.1002/cncr.32726.
    PubMed    
    
    
    
27. GAISA MM, Liu Y, Deshmukh AA, Stone KL, et al
    Electrocautery ablation of anal high-grade squamous intraepithelial lesions: Effectiveness and key factors associated with outcomes.
    Cancer. 2020 Jan 24. doi: 10.1002/cncr.32581.
    PubMed     Abstract available
    
    
    
28. KROENKE CH, Paskett ED, Cene CW, Caan BJ, et al
    Prediagnosis social support, social integration, living status, and colorectal cancer mortality in postmenopausal women from the women's health initiative.
    Cancer. 2020 Jan 23. doi: 10.1002/cncr.32710.
    PubMed     Abstract available
    
    
    
29. UPPAL A, Smieliauskas F, Sharma MR, Maron SB, et al
    Facilities that service economically advantaged neighborhoods perform surgical metastasectomy more often for patients with colorectal liver metastases.
    Cancer. 2020;126:281-292.
    PubMed     Abstract available
    
    
    
30. SYMONDS EL, Pedersen SK, Murray D, Byrne SE, et al
    Circulating epigenetic biomarkers for detection of recurrent colorectal cancer.
    Cancer. 2020 Jan 7. doi: 10.1002/cncr.32695.
    PubMed     Abstract available
    
    
    December 2019
31. ONYEAGHALA G, Lintelmann AK, Joshu CE, Lutsey PL, et al
    Adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention guidelines and colorectal cancer incidence among African Americans and whites: The Atherosclerosis Risk in Communities study.
    Cancer. 2019 Dec 24. doi: 10.1002/cncr.32616.
    PubMed     Abstract available
    
    
    
32. FEDEWA SA, Siegel RL, Goding Sauer A, Bandi P, et al
    Colorectal cancer screening patterns after the American Cancer Society's recommendation to initiate screening at age 45 years.
    Cancer. 2019 Dec 18. doi: 10.1002/cncr.32662.
    PubMed    
    
    
    November 2019
33. RAMIREZ AG, Choi BY, Munoz E, Perez A, et al
    Assessing the effect of patient navigator assistance for psychosocial support services on health-related quality of life in a randomized clinical trial in Latino breast, prostate, and colorectal cancer survivors.
    Cancer. 2019 Nov 19. doi: 10.1002/cncr.32626.
    PubMed     Abstract available
    
    
    
34. DUHAMEL KN, Schofield EA, Villagra C, Sriphanlop P, et al
    Promoting colonoscopy screening among low-income Latinos at average risk of colorectal cancer: A randomized clinical trial.
    Cancer. 2019 Nov 19. doi: 10.1002/cncr.32541.
    PubMed     Abstract available
    
    
    
35. HUNG P, Deng S, Zahnd WE, Adams SA, et al
    Geographic disparities in residential proximity to colorectal and cervical cancer care providers.
    Cancer. 2019 Nov 8. doi: 10.1002/cncr.32594.
    PubMed     Abstract available
    
    
    October 2019
36. CORONADO GD, Green BB, West II, Schwartz MR, et al
    Direct-to-member mailed colorectal cancer screening outreach for Medicaid and Medicare enrollees: Implementation and effectiveness outcomes from the BeneFIT study.
    Cancer. 2019 Oct 28. doi: 10.1002/cncr.32567.
    PubMed     Abstract available
    
    
    
37. PRINTZ C
    Western States Show Biggest Increase in Early-Onset Colorectal Cancer.
    Cancer. 2019;125:3487.
    PubMed    
    
    
    
38. CROCETTI E, Giuliani O, Mancini S, Bucchi L, et al
    Colorectal cancer incidence trends among Italian individuals aged younger than 50 years is decreasing.
    Cancer. 2019 Oct 3. doi: 10.1002/cncr.32537.
    PubMed    
    
    
    
39. PRINTZ C
    First person profile: Albert de la Chapelle, MD, PhD: Known for several pioneering discoveries in genetics, Dr. de la Chapelle is working to shed light on the genes that cause thyroid cancer.
    Cancer. 2019;125:3285-3286.
    PubMed    
    
    
    September 2019
40. JONES WF, Ahnen DJ, Schroy PC 3rd
    Improving on-time colorectal cancer screening through lead time messaging.
    Cancer. 2019 Sep 30. doi: 10.1002/cncr.32535.
    PubMed    
    
    
    
41. MYERS RE
    Low rates of diagnostic colonoscopy in Federally Qualified Health Centers: A persistent problem that must be addressed to achieve the promise of colorectal cancer screening.
    Cancer. 2019 Sep 3. doi: 10.1002/cncr.32438.
    PubMed    
    
    
    August 2019
42. VEENSTRA CM, Hawley ST, McLeod MC, Banerjee M, et al
    Partnered status and receipt of guideline-concordant adjuvant chemotherapy among patients with colon cancer.
    Cancer. 2019 Aug 21. doi: 10.1002/cncr.32459.
    PubMed     Abstract available
    
    
    
43. PIAWAH S, Venook AP
    Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer.
    Cancer. 2019 Aug 21. doi: 10.1002/cncr.32163.
    PubMed     Abstract available
    
    
    July 2019
44. ARNOLD CL, Rademaker AW, Morris JD, Ferguson LA, et al
    Follow-up approaches to a health literacy intervention to increase colorectal cancer screening in rural community clinics: A randomized controlled trial.
    Cancer. 2019 Jul 29. doi: 10.1002/cncr.32398.
    PubMed     Abstract available
    
    
    
45. VIROSTKO J, Capasso A, Yankeelov TE, Goodgame B, et al
    Recent trends in the age at diagnosis of colorectal cancer in the US National Cancer Data Base, 2004-2015.
    Cancer. 2019 Jul 22. doi: 10.1002/cncr.32347.
    PubMed     Abstract available
    
    
    
46. DOUBENI CA
    Early-onset colorectal cancer: What reported statistics can and cannot tell us and their implications.
    Cancer. 2019 Jul 22. doi: 10.1002/cncr.32346.
    PubMed    
    
    
    
47. TENG A, Nelson DW, Dehal A, Chang SC, et al
    Colon cancer as a subsequent malignant neoplasm in young adults.
    Cancer. 2019 Jul 10. doi: 10.1002/cncr.32325.
    PubMed     Abstract available
    
    
    June 2019
48. ABDELAZIM YA, Rushing CN, Palta M, Willett CG, et al
    Role of pelvic chemoradiation therapy in patients with initially metastatic anal canal cancer: A National Cancer Database review.
    Cancer. 2019;125:2115-2122.
    PubMed     Abstract available
    
    
    May 2019
49. MARSHALL CH, Al-Mallah MH, Dardari Z, Brawner CA, et al
    Cardiorespiratory fitness and incident lung and colorectal cancer in men and women: Results from the Henry Ford Exercise Testing (FIT) cohort.
    Cancer. 2019 May 6. doi: 10.1002/cncr.32085.
    PubMed     Abstract available
    
    
    April 2019
50. GEORGE TJ, Franke AJ, Chakravarthy AB, Das P, et al
    National Cancer Institute (NCI) state of the science: Targeted radiosensitizers in colorectal cancer.
    Cancer. 2019 Apr 24. doi: 10.1002/cncr.32150.
    PubMed     Abstract available
    
    
    
51. TSUI J, DeLia D, Stroup AM, Nova J, et al
    Association of Medicaid enrollee characteristics and primary care utilization with cancer outcomes for the period spanning Medicaid expansion in New Jersey.
    Cancer. 2019;125:1330-1340.
    PubMed     Abstract available
    
    
    March 2019
52. SAAD AM, Gad MM, Al-Husseini MJ, AlKhayat MA, et al
    Suicidal death within a year of a cancer diagnosis: A population-based study.
    Cancer. 2019;125:972-979.
    PubMed     Abstract available
    
    
    
53. ESPLEN MJ, Harrington S, Leung YW, Aronson M, et al
    Telephone versus in-person colorectal cancer risk and screening intervention for first-degree relatives: A randomized controlled trial.
    Cancer. 2019 Mar 12. doi: 10.1002/cncr.32032.
    PubMed     Abstract available
    
    
    
54. WILLAUER AN, Liu Y, Pereira AAL, Lam M, et al
    Clinical and molecular characterization of early-onset colorectal cancer.
    Cancer. 2019 Mar 11. doi: 10.1002/cncr.31994.
    PubMed     Abstract available
    
    
    
55. WU Y, Liang Y, Zhou Q, Liu H, et al
    Effectiveness of a short message service intervention to motivate people with positive results in preliminary colorectal cancer screening to undergo colonoscopy: A randomized controlled trial.
    Cancer. 2019 Mar 2. doi: 10.1002/cncr.32043.
    PubMed     Abstract available
    
    
    January 2019
56. CORRIGAN KL, Wall KC, Bartlett JA, Suneja G, et al
    Cancer disparities in people with human immunodeficiency virus: A systematic review of screening for non-AIDS-defining malignancies.
    Cancer. 2019 Jan 15. doi: 10.1002/cncr.31838.
    PubMed     Abstract available
    
    
    December 2018
57. ESKANDER RN
    Mismatch repair in endometrioid endometrial cancer: Increasing our therapeutic proficiency by capitalizing on molecular deficiency.
    Cancer. 2018 Dec 18. doi: 10.1002/cncr.31902.
    PubMed    
    
    
    
58. BACKES FJ, Haag J, Cosgrove CM, Suarez A, et al
    Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker.
    Cancer. 2018 Dec 18. doi: 10.1002/cncr.31901.
    PubMed     Abstract available
    
    
    
59. RIGTER LS, Spaander MCW, Aleman BMP, Bisseling TM, et al
    High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors.
    Cancer. 2018 Dec 18. doi: 10.1002/cncr.31903.
    PubMed     Abstract available
    
    
    
60. RICE K, Sharma K, Li C, Butterly L, et al
    Cost-effectiveness of a patient navigation intervention to increase colonoscopy screening among low-income adults in New Hampshire.
    Cancer. 2018 Dec 12. doi: 10.1002/cncr.31864.
    PubMed     Abstract available
    
    
    November 2018
61. ZHANG D, Matthews CE, Powell-Wiley TM, Xiao Q, et al
    Ten-year change in neighborhood socioeconomic status and colorectal cancer.
    Cancer. 2018 Nov 13. doi: 10.1002/cncr.31832.
    PubMed     Abstract available
    
    
    
62. RESNICK MJ, Graves AJ, Gambrel RJ, Thapa S, et al
    The association between medicare accountable care organization enrollment and breast, colorectal, and prostate cancer screening.
    Cancer. 2018 Nov 9. doi: 10.1002/cncr.31700.
    PubMed     Abstract available
    
    
    October 2018
63. LARA CL, Means KL, Morwood KD, Lighthall WR, et al
    Colorectal cancer screening interventions in 2 health care systems serving disadvantaged populations: Screening uptake and cost-effectiveness.
    Cancer. 2018 Oct 25. doi: 10.1002/cncr.31691.
    PubMed     Abstract available
    
    
    
64. TANGKA FKL, Subramanian S, DeGroff AS, Wong FL, et al
    Identifying optimal approaches to implement colorectal cancer screening through participation in a learning laboratory.
    Cancer. 2018 Oct 25. doi: 10.1002/cncr.31679.
    PubMed    
    
    
    
65. KIM KE, Randal F, Johnson M, Quinn M, et al
    Economic assessment of patient navigation to colonoscopy-based colorectal cancer screening in the real-world setting at the University of Chicago Medical Center.
    Cancer. 2018 Oct 25. doi: 10.1002/cncr.31690.
    PubMed     Abstract available
    
    
    
66. DACUS HLM, Wagner VL, Collins EA, Matson JM, et al
    Evaluation of patient-focused interventions to promote colorectal cancer screening among New York state Medicaid managed care patients.
    Cancer. 2018 Oct 25. doi: 10.1002/cncr.31692.
    PubMed     Abstract available
    
    
    
67. KEMPER KE, Glaze BL, Eastman CL, Waldron RC, et al
    Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in washington state.
    Cancer. 2018 Oct 25. doi: 10.1002/cncr.31693.
    PubMed     Abstract available
    
    
    
68. SUBRAMANIAN S, Hoover S, Tangka FKL, DeGroff A, et al
    A conceptual framework and metrics for evaluating multicomponent interventions to increase colorectal cancer screening within an organized screening program.
    Cancer. 2018 Oct 25. doi: 10.1002/cncr.31686.
    PubMed     Abstract available
    
    
    
69. ORTIZ AP, Engels EA, Nogueras-Gonzalez GM, Colon-Lopez V, et al
    Disparities in human papillomavirus-related cancer incidence and survival among human immunodeficiency virus-infected hispanics living in the United States.
    Cancer. 2018 Oct 22. doi: 10.1002/cncr.31702.
    PubMed     Abstract available
    
    
    
70. CHU JN, Choi J, Ostvar S, Torchia JA, et al
    Cost-effectiveness of immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer.
    Cancer. 2018 Oct 21. doi: 10.1002/cncr.31795.
    PubMed     Abstract available
    
    
    September 2018
71. 
    American Cancer Society updates its colorectal cancer screening guideline: New recommendation is to start screening at age 45 years.
    Cancer. 2018;124:3631-3632.
    PubMed    
    
    
    
72. CHANGOOR NR, Pak LM, Nguyen LL, Bleday R, et al
    Effect of an Equal-Access Military Health System on Racial Disparities in Colorectal Cancer Screening.
    Cancer. 2018 Sep 12. doi: 10.1002/cncr.31637.
    PubMed     Abstract available
    
    
    
73. 
    Erratum: Long Y, Sanchez-Espiridion B, Lin M, et al. Global and targeted serum metabolic profiling of colorectal cancer progression. Cancer. 2018;124: 785-796.
    Cancer. 2018;124:3621.
    PubMed    
    
    
    July 2018
74. PRINTZ C
    Declines in death from colorectal cancer in europe deemed major success.
    Cancer. 2018;124:2876.
    PubMed    
    
    
    June 2018
75. SANOFF HK, Goldberg RM, Ivanova A, O'Reilly S, et al
    Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancer.
    Cancer. 2018 Jun 15. doi: 10.1002/cncr.31552.
    PubMed     Abstract available
    
    
    May 2018
76. MEESTER RGS, Peterse EFP, Knudsen AB, de Weerdt AC, et al
    Optimizing colorectal cancer screening by race and sex: Microsimulation analysis II to inform the American Cancer Society colorectal cancer screening guideline.
    Cancer. 2018 May 30. doi: 10.1002/cncr.31542.
    PubMed     Abstract available
    
    
    
77. PETERSE EFP, Meester RGS, Siegel RL, Chen JC, et al
    The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline.
    Cancer. 2018 May 30. doi: 10.1002/cncr.31543.
    PubMed     Abstract available
    
    
    
78. KROENKE CH, Prado CM, Meyerhardt JA, Weltzien EK, et al
    Muscle radiodensity and mortality in patients with colorectal cancer.
    Cancer. 2018 May 24. doi: 10.1002/cncr.31405.
    PubMed     Abstract available
    
    
    
79. ADAR T, Rodgers LH, Shannon KM, Yoshida M, et al
    Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome.
    Cancer. 2018 May 11. doi: 10.1002/cncr.31534.
    PubMed     Abstract available
    
    
    April 2018
80. AZAR I, Esfandiarifard S, Sinai P, Mehdi S, et al
    Colon cancer survival in the US Department of Veterans Affairs by race and stage: 2001 through 2009.
    Cancer. 2018 Apr 30. doi: 10.1002/cncr.31525.
    PubMed    
    
    
    
81. WHITE A, Rim SH, Joseph DA, Johnson CJ, et al
    Reply to Colon cancer survival in the US Department of Veterans Affairs by race and stage: 2001 through 2009.
    Cancer. 2018 Apr 30. doi: 10.1002/cncr.31523.
    PubMed    
    
    
    
82. KARUTURI MS, Holmes HM, Lei X, Johnson M, et al
    Potentially inappropriate medication use in older patients with breast and colorectal cancer.
    Cancer. 2018 Apr 24. doi: 10.1002/cncr.31403.
    PubMed     Abstract available
    
    
    
83. ALATISE OI, Ayandipo OO, Adeyeye A, Seier K, et al
    A symptom-based model to predict colorectal cancer in low-resource countries: Results from a prospective study of patients at high risk for colorectal cancer.
    Cancer. 2018 Apr 12. doi: 10.1002/cncr.31399.
    PubMed     Abstract available
    
    
    
84. MOLS F, Schoormans D, de Hingh I, Oerlemans S, et al
    Symptoms of anxiety and depression among colorectal cancer survivors from the population-based, longitudinal PROFILES Registry: Prevalence, predictors, and impact on quality of life.
    Cancer. 2018 Apr 6. doi: 10.1002/cncr.31369.
    PubMed     Abstract available
    
    
    
85. TSOH JY, Tong EK, Sy AU, Stewart SL, et al
    Knowledge of colorectal cancer screening guidelines and intention to obtain screening among nonadherent Filipino, Hmong, and Korean Americans.
    Cancer. 2018;124 Suppl 7:1560-1567.
    PubMed     Abstract available
    
    
    
86. CUARESMA CF, Sy AU, Nguyen TT, Ho RCS, et al
    Results of a lay health education intervention to increase colorectal cancer screening among Filipino Americans: A cluster randomized controlled trial.
    Cancer. 2018;124 Suppl 7:1535-1542.
    PubMed     Abstract available
    
    
    
87. SY AU, Lim E, Ka'opua LS, Kataoka-Yahiro M, et al
    Colorectal cancer screening prevalence and predictors among Asian American subgroups using Medical Expenditure Panel Survey National Data.
    Cancer. 2018;124 Suppl 7:1543-1551.
    PubMed     Abstract available
    
    
    
88. TRAN MT, Jeong MB, Nguyen VV, Sharp MT, et al
    Colorectal cancer beliefs, knowledge, and screening among Filipino, Hmong, and Korean Americans.
    Cancer. 2018;124 Suppl 7:1552-1559.
    PubMed     Abstract available
    
    
    
89. SUN A, Tsoh JY, Tong EK, Cheng J, et al
    A physician-initiated intervention to increase colorectal cancer screening in Chinese patients.
    Cancer. 2018;124 Suppl 7:1568-1575.
    PubMed     Abstract available
    
    
    March 2018
90. BLACK DS, Cole SW, Christodoulou G, Figueiredo JC, et al
    Genomic mechanisms of fatigue in survivors of colorectal cancer.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31356.
    PubMed     Abstract available
    
    
    
91. POLITE BN, Cipriano-Steffens TM, Hlubocky FJ, Jean-Pierre P, et al
    Association of externalizing religious and spiritual beliefs on stage of colon cancer diagnosis among black and white multicenter urban patient populations.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31351.
    PubMed     Abstract available
    
    
    
92. PISHVAIAN MJ, Slack RS, Jiang W, He AR, et al
    A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31309.
    PubMed     Abstract available
    
    
    February 2018
93. EBERTH JM, Thibault A, Caldwell R, Josey MJ, et al
    A statewide program providing colorectal cancer screening to the uninsured of South Carolina.
    Cancer. 2018 Feb 7. doi: 10.1002/cncr.31250.
    PubMed     Abstract available
    
    
    January 2018
94. ROSS JS, Fakih M, Ali SM, Elvin JA, et al
    Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.
    Cancer. 2018 Jan 16. doi: 10.1002/cncr.31125.
    PubMed     Abstract available
    
    
    
95. PRINTZ C
    Death rates for colorectal cancer rising for individuals aged younger than 55 years.
    Cancer. 2018;124:229.
    PubMed    
    
    
    
96. RILEY JM, Cross AW, Paulos CM, Rubinstein MP, et al
    The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine.
    Cancer. 2018 Jan 9. doi: 10.1002/cncr.31214.
    PubMed     Abstract available
    
    
    
97. PRINTZ C
    Study finds link between inflammation and colorectal cancer.
    Cancer. 2018;124:13.
    PubMed    
    
    
    
98. RAZZAGHI H, Saraiya M, Thompson TD, Henley SJ, et al
    Five-year relative survival for human papillomavirus-associated cancer sites.
    Cancer. 2018;124:203-211.
    PubMed     Abstract available
    
    
    December 2017
99. WHITE A, Joseph D, Rim SH, Johnson CJ, et al
    Colon cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:5014-5036.
    PubMed     Abstract available
    
    
    
100. JOSEPH DA, Johnson CJ, White A, Wu M, et al
     Rectal cancer survival in the United States by race and stage, 2001 to 2009: Findings from the CONCORD-2 study.
     Cancer. 2017;123 Suppl 24:5037-5058.
     PubMed     Abstract available
     
     
     
101. DOROUDI M, Schoen RE, Pinsky PF
     Early detection versus primary prevention in the PLCO flexible sigmoidoscopy screening trial: Which has the greatest impact on mortality?
     Cancer. 2017;123:4815-4822.
     PubMed     Abstract available
     
     
     
102. MEROPOL NJ, Feng Y, Grem JL, Mulcahy MF, et al
     Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG-ACRIN Cancer Research Group (E4203).
     Cancer. 2017 Dec 6. doi: 10.1002/cncr.30967.
     PubMed     Abstract available
     
     
     
103. NIXON NA, Khan OF, Imam H, Tang PA, et al
     Drug development for breast, colorectal, and non-small cell lung cancers from 1979 to 2014.
     Cancer. 2017;123:4672-4679.
     PubMed     Abstract available
     
     
     November 2017
104. TRICOLI JV, Boardman LA, Patidar R, Sindiri S, et al
     A mutational comparison of adult and adolescent and young adult (AYA) colon cancer.
     Cancer. 2017 Nov 30. doi: 10.1002/cncr.31136.
     PubMed     Abstract available
     
     
     
105. SARMA EA, Kawachi I, Poole EM, Tworoger SS, et al
     Social integration and survival after diagnosis of colorectal cancer.
     Cancer. 2017 Nov 21. doi: 10.1002/cncr.31117.
     PubMed     Abstract available
     
     
     
106. ZHAO H, Zhang N, Ho V, Ding M, et al
     Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011.
     Cancer. 2017 Nov 15. doi: 10.1002/cncr.31094.
     PubMed     Abstract available
     
     
     
107. CASSIDY RJ, Switchenko JM, Cheng E, Jiang R, et al
     Health care disparities among octogenarians and nonagenarians with stage II and III rectal cancer.
     Cancer. 2017;123:4325-4336.
     PubMed     Abstract available
     
     
     
108. ZHANG J, Raju GS, Chang DW, Lin SH, et al
     Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
     Cancer. 2017 Nov 7. doi: 10.1002/cncr.31062.
     PubMed     Abstract available
     
     
     October 2017
109. PRINTZ C
     Some stage III colon cancer patients may need only half of the standard chemotherapy course.
     Cancer. 2017;123:3871.
     PubMed    
     
     
     
110. CHAD-FRIEDMAN E, Coleman S, Traeger LN, Pirl WF, et al
     Psychological distress associated with cancer screening: A systematic review.
     Cancer. 2017;123:3882-3894.
     PubMed     Abstract available
     
     
     
111. LEVI Z, Kark JD, Katz LH, Twig G, et al
     Adolescent body mass index and risk of colon and rectal cancer in a cohort of 1.79 million Israeli men and women: A population-based study.
     Cancer. 2017;123:4022-4030.
     PubMed     Abstract available
     
     
     
112. NELSON RA, Lai LL
     Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
     Cancer. 2017;123:4013-4021.
     PubMed     Abstract available
     
     
     
113. SEGNAN N, Armaroli P
     Early detection versus prevention in colorectal cancer screening: Methods estimates and public health implications.
     Cancer. 2017 Oct 4. doi: 10.1002/cncr.31032.
     PubMed    
     
     
     
114. HONG YR, Tauscher J, Cardel M
     Distrust in health care and cultural factors are associated with uptake of colorectal cancer screening in Hispanic and Asian Americans.
     Cancer. 2017 Oct 4. doi: 10.1002/cncr.31052.
     PubMed     Abstract available
     
     
     September 2017
115. DESHMUKH AA, Chiao EY, Cantor SB, Stier EA, et al
     Management of precancerous anal intraepithelial lesions in human immunodeficiency virus-positive men who have sex with men: Clinical effectiveness and cost-effectiveness.
     Cancer. 2017 Sep 26. doi: 10.1002/cncr.31035.
     PubMed     Abstract available
     
     
     
116. SADETZKI S, Chetrit A, Freedman LS, Hakak N, et al
     Cancer risk among Holocaust survivors in Israel-A nationwide study.
     Cancer. 2017;123:3335-3345.
     PubMed     Abstract available
     
     
     August 2017
117. MEDHANIE GA, Fedewa SA, Adissu H, DeSantis CE, et al
     Cancer incidence profile in sub-Saharan African-born blacks in the United States: Similarities and differences with US-born non-Hispanic blacks.
     Cancer. 2017;123:3116-3124.
     PubMed     Abstract available
     
     
     
118. JAGAI JS, Messer LC, Rappazzo KM, Gray CL, et al
     County-level cumulative environmental quality associated with cancer incidence.
     Cancer. 2017;123:2901-2908.
     PubMed     Abstract available
     
     
     
119. MALAPELLE U, Mayo-de-Las-Casas C, Molina-Vila MA, Rosell R, et al
     Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.
     Cancer. 2017;125:615-626.
     PubMed     Abstract available
     
     
     December 2016
120. GULATI R, Albertsen PC
     Insights from the PLCO trial about prostate cancer screening.
     Cancer. 2016 Dec 1. doi: 10.1002/cncr.30472.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: